These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10205288)

  • 1. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
    Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
    Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells.
    Clunn GF; Lymn JS; Schachter M; Hughes AD
    Br J Pharmacol; 1997 Aug; 121(8):1789-95. PubMed ID: 9283719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of virus-transformation and growth factor stimulation on isoprene biosynthesis in human fibroblasts: a correlation to cell growth.
    Larsson O
    Cancer Biochem Biophys; 1995 Jan; 14(4):243-56. PubMed ID: 7767898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
    Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
    Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mevalonate deprivation alters the induction of fos and myc by growth factors.
    Barbu V; Dautry F
    Oncogene; 1990 Jul; 5(7):1077-80. PubMed ID: 2115642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
    del Rio M; Sunkel C; Larcher F; Ortega MP
    Br J Pharmacol; 1997 Apr; 120(7):1360-6. PubMed ID: 9105713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size.
    Berk BC; Rao GN
    J Cell Physiol; 1993 Feb; 154(2):368-80. PubMed ID: 8425918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to increased expression of IGF-1 receptors in human fibroblasts.
    Carlberg M; Larsson O
    Exp Cell Res; 1996 Feb; 223(1):142-8. PubMed ID: 8635486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J; Wojakowski W
    Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
    Luan Z; Chase AJ; Newby AC
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
    Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
    Hu WL; Qiao SB; Li JJ
    Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of protooncogenes during lymphocyte activation by growth factors.
    Bulanova EG; Budagyan VM; Yarilin AA; Mazurenko NN
    Biochemistry (Mosc); 1997 Sep; 62(9):1021-5. PubMed ID: 9457764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.